Progyny Net Worth
Progyny Net Worth Breakdown | PGNY |
Progyny Net Worth Analysis
Progyny's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Progyny's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Progyny's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Progyny's net worth analysis. One common approach is to calculate Progyny's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Progyny's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Progyny's net worth. This approach calculates the present value of Progyny's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Progyny's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Progyny's net worth. This involves comparing Progyny's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Progyny's net worth relative to its peers.
Enterprise Value |
|
To determine if Progyny is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Progyny's net worth research are outlined below:
| Progyny generated a negative expected return over the last 90 days | |
| Progyny has high historical volatility and very poor performance | |
| Progyny is unlikely to experience financial distress in the next 2 years | |
| Over 93.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Meridian Hedged Equity Fund Decided to Sell its Holdings in Progyny . Heres Why |
Progyny Quarterly Good Will |
|
Progyny uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Progyny. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Progyny's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Progyny's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Progyny is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Progyny backward and forwards among themselves. Progyny's institutional investor refers to the entity that pools money to purchase Progyny's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Riverbridge Partners Llc | 2024-09-30 | 1.7 M | Owls Nest Partners Ia, Llc | 2024-09-30 | 1.5 M | Clearbridge Advisors, Llc | 2024-09-30 | 1.3 M | Bank Of America Corp | 2024-06-30 | 1.2 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.1 M | Macquarie Group Ltd | 2024-06-30 | 1.1 M | Northern Trust Corp | 2024-09-30 | 1 M | Kornitzer Capital Management Inc | 2024-09-30 | 976.5 K | Rockefeller Capital Management L.p. | 2024-06-30 | 975.2 K | Blackrock Inc | 2024-06-30 | 11.8 M | Vanguard Group Inc | 2024-09-30 | 8.6 M |
Follow Progyny's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.33 B.Market Cap |
|
Project Progyny's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.09 | |
| Return On Capital Employed | 0.11 | 0.11 | |
| Return On Assets | 0.08 | 0.09 | |
| Return On Equity | 0.11 | 0.12 |
When accessing Progyny's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Progyny's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Progyny's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Progyny's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Progyny. Check Progyny's Beneish M Score to see the likelihood of Progyny's management manipulating its earnings.
Evaluate Progyny's management efficiency
Progyny has return on total asset (ROA) of 0.059 % which means that it generated a profit of $0.059 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1205 %, meaning that it created $0.1205 on every $100 dollars invested by stockholders. Progyny's management efficiency ratios could be used to measure how well Progyny manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.09 in 2024. Return On Capital Employed is likely to rise to 0.11 in 2024. At this time, Progyny's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 440.7 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 69.4 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.82 | 6.12 | |
| Tangible Book Value Per Share | 5.70 | 5.98 | |
| Enterprise Value Over EBITDA | 53.59 | 56.27 | |
| Price Book Value Ratio | 6.38 | 6.06 | |
| Enterprise Value Multiple | 53.59 | 56.27 | |
| Price Fair Value | 6.38 | 6.06 | |
| Enterprise Value | 3.5 B | 2.2 B |
Leadership effectiveness at Progyny is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Enterprise Value Revenue 0.9719 | Revenue 1.1 B | Quarterly Revenue Growth 0.02 | Revenue Per Share 12.279 | Return On Equity 0.1205 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Progyny insiders, such as employees or executives, is commonly permitted as long as it does not rely on Progyny's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Progyny insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Progyny Corporate Filings
F4 | 27th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 7th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Progyny Earnings per Share Projection vs Actual
Progyny Corporate Management
| Julie Stadlbauer | Ex Partnerships | Profile | |
| Katie Higgins | Chief Officer | Profile | |
| Risa Fisher | Chief Officer | Profile | |
| Cassandra Pratt | Senior People | Profile | |
| Peter Anevski | CEO Director | Profile | |
| Steven Leist | Chief Officer | Profile | |
| Michael Sturmer | President | Profile |
Additional Tools for Progyny Stock Analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.